Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and efficacy of neoadjuvant immunotherapy
combined with chemotherapy before colonic resection in patients with locally advanced colon
cancers